No Data
No Data
Piper Sandler Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Cuts Target Price to $6
Piper Sandler Sticks to Its Buy Rating for Repare Therapeutics (RPTX)
Express News | Repare Therapeutics Inc : Piper Sandler Cuts Target Price to $6 From $25
Analysts Offer Insights on Healthcare Companies: Repare Therapeutics (RPTX) and Centene (CNC)
Institutional Investors May Adopt Severe Steps After Repare Therapeutics Inc.'s (NASDAQ:RPTX) Latest 44% Drop Adds to a Year Losses
Morgan Stanley Maintains Repare Therapeutics(RPTX.US) With Hold Rating, Maintains Target Price $8
Unlock the Full List